User:Chrysalism/sandbox

Dr. Radhika Nair is an Indian cancer biology researcher. She currently serves as the Ramanujan Faculty Fellow at the Rajiv Gandhi Centre for Biotechnology, in Trivandrum, India, and Senior Research Officer at Garvan Institute of Medical Research in Darlinghurst, Sydney, New South Wales, Australia. She specializes in understanding the cell intrinsic mechanisms that allow tumor cells to survive, go dormant and then thrive, specifically in breast cancer.

Education and Career
After receiving a BSc. in Microbiology and Biochemistry at St. Xavier's College and an MSc in Biochemistry at the Institute of Science, Mumbai both in Bombay, India, Nair attended the National Institute of Immunology, India (NII) in Delhi. Her PhD work focused on germ cell death. In 2005, Nair was awarded a post-doctoral Career Development Fellowship in the MRC Cancer Unit at the University of Cambridge, focusing on microbial and eukaryotic genetics.

The UK fellowship was followed by several years as a research scientist at Garvan, working with Dr. Alexander Swarbrick, head of the cancer center at the institute. After losing a friend who was suffering from breast cancer, Dr. Nair dedicated her life to breast cancer research. While at Garvan, Nair contributed to a collaborative program called ProMis (Prostate Cancer Metastasis). Nair also lectured at St. Vincent's Clinical School at the University of New South Wales in Sydney, Australia.

She has discovered the interaction between the her2-type of cancer and myc, a gene.

Publications

 * Diethylstilbestrol Induces Rat Spermatogenic Cell Apoptosis in Vivo through Increased Expression of Spermatogenic Cell Fas/FasL System (2003)
 * Redefining the Expression and Function of the Inhibitor of Differentiation 1 in Mammary Gland Development (2010)
 * Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells (2010)
 * Genome-wide screening for genes that regulate the metastasis of breast cancer (2011)
 * Abstract S6-8: Hedgehog Ligand Overexpression Predicts Poor Outcome in Breast Cancer and Is a Potential Therapeutic Target for Metastatic Disease (2010)
 * Dissecting the Role of the Inhibitor of Differentiation 1 in Breast Cancer Metastasis and Characterization of Pathways Controlling Breast Cancer Stem Cell Phenotype (2012)
 * Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer (2012)
 * Interleukin-27 Signaling Promotes Immunity against Endogenously Arising Murine Tumors (2013)
 * The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy (2013)
 * C-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer (2014)
 * Toxin Kid uncouples DNA replication and cell division to enforce retention of plasmid R1 in Escherichia coli cells (2014)
 * ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities (2014)
 * New insights into the role of ID proteins in breast cancer metastasis: A MET affair (2014)
 * Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signaling networks and conserved oncogenic pathways. (2014)
 * ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype (2015)
 * The Inhibitor of Differentiation proteins mediate tumour-initiating properties and metastasis in breast cancer (2015)
 * ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype (2015)
 * Targeting the hedgehog signalling pathway in triple negative breast cancer (2015)
 * MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene (2015)
 * The role of cancer stem cells in tumor heterogeneity and resistance to therapy (2016)